Truncated forms of BNIP3 act as dominant negatives inhibiting hypoxia-induced cell death

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 3, 2011, Pages 302-311

  Bristow, Nicolle ^a   Burton, Teralee R ^a,b   Henson, Elizabeth S ^a,b   Ong Justiniano, Coleen ^a   Brown, Michelle ^a   Gibson, Spencer B ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bcl 2 family; BNIP3; Cell death and cancer; Hypoxia; Normoxia

Indexed keywords

BH3 PROTEIN; PROTEIN BNIP3;

ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL STRAIN HEK293; CELL STRAIN MCF 7; CELL STRAIN SKOV3; CONTROLLED STUDY; EMBRYO; GENE MUTATION; HUMAN; HUMAN CELL; HYPOXIA; HYPOXIA INDUCED CELL DEATH; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALS; ANOXIA; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GENES, DOMINANT; HUMANS; IMMUNOENZYME TECHNIQUES; MEMBRANE PROTEINS; MICE; MITOCHONDRIA; MUTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

ADENOVIRIDAE;

EID: 78650601580     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.11.013     Document Type: Article

References (34)

1. Zhang H.M., Cheung P., Yanagawa B., McManus B.M., Yang D.C. BNips: a group of pro-apoptotic proteins in the Bcl-2 family. Apoptosis 2003, 8:229-236.
2. Yasuda M., Theodorakis P., Subramanian T., Chinnadurai G. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J. Biol. Chem. 1998, 273:12415-12421.
3. Chen G., Cizeau J., Vande Velde C., Park J.H., Bozek G., Bolton J., Shi L., Dubik D., Greenberg A. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J. Biol. Chem. 1999, 274:7-10.
4. Yasuda M., Han J.W., Dionne C.A., Boyd J.M., Chinnadurai G. BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3. Cancer Res. 1999, 59:533-537.
5. Kothari S., Cizeau J., McMillan-Ward E., Israels S.J., Bailes M., Ens K., Kirshenbaum L.A., Gibson S.B. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003, 22:4734-4744.
6. Bruick R.K. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl Acad. Sci. USA 2000, 97:9082-9087.
7. An H.J., Maeng O., Kang K.H., Lee J.O., Kim Y.S., Paik S.G., Lee H. Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death. J. Biol. Chem. 2006, 281:33939-33948.
8. Azad M.B., Chen Y., Henson E.S., Cizeau J., McMillan-Ward E., Israels S.J., Gibson S.B. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008, 4:195-204.
9. Daido S., Kanzawa T., Yamamoto A., Takeuchi H., Kondo Y., Kondo S. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res. 2004, 64:4286-4293.
10. Kanzawa T., Zhang L., Xiao L., Germano I.M., Kondo Y., Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 2005, 24:980-991.
11. Searle J., Kerr J.F., Bishop C.J. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol. Annu. 1982, 17(Pt 2):229-259.
12. Prabhakaran K., Li L., Zhang L., Borowitz J.L., Isom G.E. Upregulation of BNIP3 and translocation to mitochondria mediates cyanide-induced apoptosis in cortical cells. Neuroscience 2007, 150:159-167.
13. Regula K.M., Ens K., Kirshenbaum L.A. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ. Res. 2002, 91:226-231.
14. Sandau U.S., Handa R.J. Localization and developmental ontogeny of the pro-apoptotic Bnip3 mRNA in the postnatal rat cortex and hippocampus. Brain Res. 2006, 1100:55-63.
15. Wan J., Martinvalet D., Ji X., Lois C., Kaech S.M., Von Andrian U.H., Lieberman J., Ahmed R., Manjunath N. The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes. Immunology 2003, 110:10-17.
16. Galluzzi L., Joza N., Tasdemir E., Maiuri M.C., Hengartner M., Abrams J.M., Tavernarakis N., Penninger J., Madeo F., Kroemer G. No death without life: vital functions of apoptotic effectors. Cell Death Differ. 2008, 15:1113-1123.
17. Hamacher-Brady A., Brady N.R., Gottlieb R.A., Gustafsson A.B. Autophagy as a protective response to Bnip3-mediated apoptotic signaling in the heart. Autophagy 2006, 2:307-309.
18. Kubli D.A., Ycaza J.E., Gustafsson A.B. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem. J. 2007, 405(3):407-415.
19. Ray R., Chen G., Vande Velde C., Cizeau J., Park J.H., Reed J.C., Gietz R.D., Greenberg A.H. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J. Biol. Chem. 2000, 275:1439-1448.
20. Cizeau J., Ray R., Chen G., Gietz R.D., Greenberg A.H. The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism. Oncogene 2000, 19:5453-5463.
21. Kim J.Y., Cho J.J., Ha J., Park J.H. The carboxy terminal C-tail of BNip3 is crucial in induction of mitochondrial permeability transition in isolated mitochondria. Arch. Biochem. Biophys. 2002, 398:147-152.
22. Bocharov E.V., Pustovalova Y.E., Pavlov K.V., Volynsky P.E., Goncharuk M.V., Ermolyuk Y.S., Karpunin D.V., Schulga A.A., Kirpichnikov M.P., Efremov R.G., Maslennikov I.V., Arseniev A.S. Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. J. Biol. Chem. 2007, 282:16256-16266.
23. Burton T.R., Henson E.S., Baijal P., Eisenstat D.D., Gibson S.B. The pro-cell death Bcl-2 family member, BNIP3, is localized to the nucleus of human glial cells: implications for glioblastoma multiforme tumor cell survival under hypoxia. Int. J. Cancer 2006, 118:1660-1669.
24. E.S. Henson, X. Hu and S.B. Gibson, Herceptin sensitizes ErbB2 (Her2/neu) over expressing cells to apoptosis by reducing anti-apoptotic Mcl-1 expression. Clin. Cancer Res. 12(3 Pt 1) (2006) 845-853.
25. Burton T.R., Gibson S.B. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death. Cell Death Differ. 2009, 16:515-523.
26. Knisely J.P., Rockwell S. Importance of hypoxia in the biology and treatment of brain tumors. Neuroimaging Clin. N. Am. 2002, 12:525-536.
27. Sannazzari G.L., Ricardi U., Filippi A.R. Hypoxia and tumor response to irradiation. Rays 2002, 27:175-179.
28. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., Hankinson O., Pugh C.W., Ratcliffe P.J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 1997, 94:8104-8109.
29. Giaccia A., Siim B.G., Johnson R.S. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2003, 2:803-811.
30. Metukuri M.R., Beer-Stolz D., Namas R.A., Dhupar R., Torres A., Loughran P.A., Jefferson B.S., Tsung A., Billiar T.R., Vodovotz Y., Zamora R. Expression and subcellular localization of BNIP3 in hypoxic hepatocytes and liver stress. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G499-G509.
31. Webster K.A., Graham R.M., Bishopric N.H. BNip3 and signal-specific programmed death in the heart. J. Mol. Cell. Cardiol. 2005, 38:35-45.
32. Zhang Z., Yang X., Zhang S., Ma X., Kong J. BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia. Stroke 2007, 38:1606-1613.
33. Bacon A.L., Fox S., Turley H., Harris A.L. Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer. Oncogene 2007, 26:132-141.
34. Okami J., Simeone D.M., Logsdon C.D. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res. 2004, 64:5338-5346.